These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23315959)

  • 1. Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study.
    Filosso PL; Galassi C; Ruffini E; Margaritora S; Bertolaccini L; Casadio C; Anile M; Venuta F
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):219-24; discussion 224. PubMed ID: 23315959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients.
    Filosso PL; Venuta F; Oliaro A; Ruffini E; Rendina EA; Margaritora S; Casadio C; Terzi A; Rena O; Lococo F; Guerrera F
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1020-7. PubMed ID: 24459215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Smoking and Histologic Subtype on Developing Extrathymic Malignancy in Thymoma Patients.
    Yanagiya M; Matsumoto J; Kawahara T; Yamaguchi H; Nagayama K; Anraku M; Sato M; Nakajima J
    Ann Thorac Surg; 2019 May; 107(5):1532-1539. PubMed ID: 30576633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrathymic malignancies in thymoma patients with and without myasthenia gravis.
    Owe JF; Cvancarova M; Romi F; Gilhus NE
    J Neurol Sci; 2010 Mar; 290(1-2):66-9. PubMed ID: 20034637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients.
    Filosso PL; Evangelista A; Ruffini E; Rendina EA; Margaritora S; Novellis P; Rena O; Casadio C; Andreetti C; Guerrera F; Lausi PO; Diso D; Mussi A; Venuta F; Oliaro A; Lucchi M
    Lung Cancer; 2015 Jun; 88(3):338-43. PubMed ID: 25819383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrathymic malignancies in patients with myasthenia gravis.
    Levin N; Abramsky O; Lossos A; Karussis D; Siegal T; Argov Z; Ben Hur T
    J Neurol Sci; 2005 Oct; 237(1-2):39-43. PubMed ID: 15990114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymomas and extrathymic cancers.
    Weksler B; Nason KS; Mackey D; Gallagher A; Pennathur A
    Ann Thorac Surg; 2012 Mar; 93(3):884-8. PubMed ID: 21962262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
    Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
    Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of thymoma still represents the first choice of treatment.
    Ried M; Guth H; Potzger T; Diez C; Neu R; Schalke B; Hofmann HS
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):145-9. PubMed ID: 21692020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different characteristics of thymomas with and without myasthenia gravis.
    Yu L; Zhang XJ; Ma S; Jing Y; Li F; Krasna MJ
    Ann Surg Oncol; 2012 Jan; 19(1):94-8. PubMed ID: 21879277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoma: prognostic factors and treatment outcomes.
    Gripp S; Hilgers K; Wurm R; Schmitt G
    Cancer; 1998 Oct; 83(8):1495-503. PubMed ID: 9781943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple thymoma with myasthenia gravis: report of a case.
    Ishibashi H; Akamatsu H; Sunamori M
    Surg Today; 2003; 33(1):49-51. PubMed ID: 12560907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancy risk in patients with bronchopulmonary carcinoids: epidemiological results from Italian Network of Cancer Registries.
    Lococo F; Galeone C; Sacchettini C; Leuzzi G; Cesario A; Paci M; Mangone L;
    Tumori; 2017 Mar; 103(2):e15-e20. PubMed ID: 28106244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical therapy of myasthenia gravis and thymoma].
    Bertram P; Treutner KH; Winkeltau G; Schumpelick V
    Chirurg; 1993 Oct; 64(10):796-801. PubMed ID: 8269744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trans-sternal thymectomy in myasthenia gravis and thymoma].
    Mönig SP; Türler A; Raab M
    Zentralbl Chir; 1995; 120(12):963-8. PubMed ID: 8585347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan.
    Kondo K; Monden Y
    Ann Thorac Surg; 2005 Jan; 79(1):219-24. PubMed ID: 15620947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited thymectomy for stage I or II thymomas.
    Onuki T; Ishikawa S; Iguchi K; Goto Y; Sakai M; Inagaki M; Yamamoto T; Onizuka M; Sato Y; Ohara K; Sakakibara Y
    Lung Cancer; 2010 Jun; 68(3):460-5. PubMed ID: 19717204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Health Organization histologic classification: an independent prognostic factor in resected thymomas.
    Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C
    Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.